11 results · 21ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

ECHELON Synergy MRI System

FDA 510(k)
FDA Class 2 ·Radiology

SORRENTO BONE GRAFT SUBSTITUTE

FDA 510(k)
FDA Class 2 ·Orthopedic

NAVIPLAN - CT Planning Software for Total Hip Replacement

FDA 510(k)
FDA Class 2 ·Radiology

DEXCOM G6 CONTINUOUS GLUCOSE MONITORING SYSTEM

FDA Adverse Event
Malfunction ·DEXCOM, INC.·Product code QBJ·January 10, 2019

RAYONE TORIC

FDA Adverse Event
Malfunction ·RAYNER INTRAOCULAR LENSES LIMITED·Product code HQL·July 31, 2024

AMS THERMATRX TMX-3000 OFFICE THERMOTHERAPY

FDA Adverse Event
Injury ·AMERICAN MEDICAL SYSTEMS (MN)·Product code MEQ·November 10, 2014

INFINITI VISION SYSTEM OZIL

FDA Adverse Event
Malfunction ·ALCON - IRVINE TECHNOLOGY CENTER·Product code HQC·August 18, 2011

ONETOUCHPING GLUCOSEMGMTSYSTEM

FDA Adverse Event
Malfunction ·ANIMAS CORPORATION·Product code LZG·July 22, 2013

ARCOS 17X150MM SPL TPR DIST

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code KWA·June 12, 2024

ARCOS CON SZ C STD 60MM

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code KWA·June 12, 2024

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014